Feasibility and potential diagnostic value of [18F]PI-2620 PET in patients with down syndrome and Alzheimer’s disease: a case series

Purpose of the reportAdults with Down Syndrome (DS) have a substantially increased risk for Alzheimer’s disease (AD) due to the triplicated amyloid-precursor-protein gene on chromosome 21, resulting in amyloid and tau accumulation. However, tau PET assessments are not sufficiently implemented in DS-...

Description complète

Détails bibliographiques

Auteurs principaux:	Olivia Wagemann, Matthias Brendel, Nicolai Franzmeier, Georg Nübling, Johannes Gnörich, Mirlind Zaganjori, Catharina Prix, Anna Stockbauer, Elisabeth Wlasich, Sandra V. Loosli, Katja Sandkühler, Lukas Frontzkowski, Günter Höglinger, Johannes Levin
Format:	Artigo
Langue:	Inglês
Publié:	Frontiers Media S.A. 2025-01-01
Collection:	Frontiers in Neuroscience
Sujets:	down syndrome Alzheimer tau PET 18F-PI-2620 case series trisomy 21
Accès en ligne:	https://www.frontiersin.org/articles/10.3389/fnins.2024.1505999/full
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!